vs
HOVNANIAN ENTERPRISES INC（HOV）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
HOVNANIAN ENTERPRISES INC的季度营收约是Royalty Pharma plc的1.3倍（$817.9M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -0.1%，领先34.5%），Royalty Pharma plc同比增速更快（4.8% vs -16.5%），过去两年HOVNANIAN ENTERPRISES INC的营收复合增速更高（17.3% vs 4.6%）
霍夫纳尼安企业是美国知名房地产企业，业务覆盖住宅开发全流程，包含设计、建造与销售，产品线丰富，不仅开发独立独栋住宅，也开发联排别墅、公寓以及养老住宅等高密度居住物业。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
HOV vs RPRX — 直观对比
营收规模更大
HOV
是对方的1.3倍
$622.0M
营收增速更快
RPRX
高出21.3%
-16.5%
净利率更高
RPRX
高出34.5%
-0.1%
两年增速更快
HOV
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $817.9M | $622.0M |
| 净利润 | $-667.0K | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | -0.5% | 62.4% |
| 净利率 | -0.1% | 34.4% |
| 营收同比 | -16.5% | 4.8% |
| 净利润同比 | -100.7% | 2.9% |
| 每股收益（稀释后） | $-0.57 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HOVRPRX
| Q4 25 | $817.9M | $622.0M | ||
| Q3 25 | $800.6M | $609.3M | ||
| Q2 25 | $686.5M | $578.7M | ||
| Q1 25 | $673.6M | $568.2M | ||
| Q4 24 | $979.6M | $593.6M | ||
| Q3 24 | $722.7M | $564.7M | ||
| Q2 24 | $708.4M | $537.3M | ||
| Q1 24 | $594.2M | $568.0M |
净利润HOVRPRX
| Q4 25 | $-667.0K | $214.2M | ||
| Q3 25 | $16.6M | $288.2M | ||
| Q2 25 | $19.7M | $30.2M | ||
| Q1 25 | $28.2M | $238.3M | ||
| Q4 24 | $94.3M | $208.2M | ||
| Q3 24 | $72.9M | $544.0M | ||
| Q2 24 | $50.8M | $102.0M | ||
| Q1 24 | $23.9M | $4.8M |
营业利润率HOVRPRX
| Q4 25 | -0.5% | 62.4% | ||
| Q3 25 | 3.0% | 70.1% | ||
| Q2 25 | 3.9% | 36.3% | ||
| Q1 25 | 5.9% | 94.0% | ||
| Q4 24 | 12.0% | 60.9% | ||
| Q3 24 | 13.5% | — | ||
| Q2 24 | 9.8% | 50.2% | ||
| Q1 24 | 5.5% | -13.0% |
净利率HOVRPRX
| Q4 25 | -0.1% | 34.4% | ||
| Q3 25 | 2.1% | 47.3% | ||
| Q2 25 | 2.9% | 5.2% | ||
| Q1 25 | 4.2% | 41.9% | ||
| Q4 24 | 9.6% | 35.1% | ||
| Q3 24 | 10.1% | 96.3% | ||
| Q2 24 | 7.2% | 19.0% | ||
| Q1 24 | 4.0% | 0.8% |
每股收益（稀释后）HOVRPRX
| Q4 25 | $-0.57 | $0.49 | ||
| Q3 25 | $1.99 | $0.67 | ||
| Q2 25 | $2.43 | $0.07 | ||
| Q1 25 | $3.58 | $0.55 | ||
| Q4 24 | $12.47 | $0.46 | ||
| Q3 24 | $9.75 | $1.21 | ||
| Q2 24 | $6.66 | $0.23 | ||
| Q1 24 | $2.91 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | $900.7M | $9.0B |
| 股东权益账面价值 | $830.9M | $9.7B |
| 总资产 | $2.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 1.08× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资HOVRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务HOVRPRX
| Q4 25 | $900.7M | $9.0B | ||
| Q3 25 | $861.9M | $8.9B | ||
| Q2 25 | $864.3M | $8.0B | ||
| Q1 25 | $893.7M | $7.6B | ||
| Q4 24 | $896.2M | $7.6B | ||
| Q3 24 | $898.7M | $7.6B | ||
| Q2 24 | $933.0M | $7.6B | ||
| Q1 24 | $934.6M | $6.1B |
股东权益HOVRPRX
| Q4 25 | $830.9M | $9.7B | ||
| Q3 25 | $835.4M | $9.6B | ||
| Q2 25 | $820.4M | $9.5B | ||
| Q1 25 | $811.4M | $9.8B | ||
| Q4 24 | $800.3M | $10.3B | ||
| Q3 24 | $703.4M | $10.3B | ||
| Q2 24 | $647.0M | $9.8B | ||
| Q1 24 | $607.1M | $9.9B |
总资产HOVRPRX
| Q4 25 | $2.6B | $19.6B | ||
| Q3 25 | $2.6B | $19.3B | ||
| Q2 25 | $2.6B | $18.3B | ||
| Q1 25 | $2.5B | $17.6B | ||
| Q4 24 | $2.6B | $18.2B | ||
| Q3 24 | $2.5B | $18.0B | ||
| Q2 24 | $2.3B | $17.7B | ||
| Q1 24 | $2.3B | $16.1B |
负债/权益比HOVRPRX
| Q4 25 | 1.08× | 0.92× | ||
| Q3 25 | 1.03× | 0.93× | ||
| Q2 25 | 1.05× | 0.84× | ||
| Q1 25 | 1.10× | 0.78× | ||
| Q4 24 | 1.12× | 0.74× | ||
| Q3 24 | 1.28× | 0.74× | ||
| Q2 24 | 1.44× | 0.78× | ||
| Q1 24 | 1.54× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $169.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $164.0M | — |
| 自由现金流率自由现金流/营收 | 20.0% | — |
| 资本支出强度资本支出/营收 | 0.6% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $166.2M | — |
8季度趋势，按日历期对齐
经营现金流HOVRPRX
| Q4 25 | $169.1M | $827.1M | ||
| Q3 25 | $52.8M | $702.6M | ||
| Q2 25 | $22.3M | $364.0M | ||
| Q1 25 | $-55.9M | $596.1M | ||
| Q4 24 | $115.8M | $742.5M | ||
| Q3 24 | $-92.3M | $703.6M | ||
| Q2 24 | $89.1M | $658.2M | ||
| Q1 24 | $-89.0M | $664.6M |
自由现金流HOVRPRX
| Q4 25 | $164.0M | — | ||
| Q3 25 | $45.8M | — | ||
| Q2 25 | $16.0M | — | ||
| Q1 25 | $-59.6M | — | ||
| Q4 24 | $111.4M | — | ||
| Q3 24 | $-95.8M | — | ||
| Q2 24 | $84.7M | — | ||
| Q1 24 | $-94.4M | — |
自由现金流率HOVRPRX
| Q4 25 | 20.0% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | -8.8% | — | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | -13.3% | — | ||
| Q2 24 | 12.0% | — | ||
| Q1 24 | -15.9% | — |
资本支出强度HOVRPRX
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.9% | — |
现金转化率HOVRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 3.18× | 2.44× | ||
| Q2 25 | 1.13× | 12.06× | ||
| Q1 25 | -1.98× | 2.50× | ||
| Q4 24 | 1.23× | 3.57× | ||
| Q3 24 | -1.27× | 1.29× | ||
| Q2 24 | 1.75× | 6.45× | ||
| Q1 24 | -3.72× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HOV
| Home Building | $789.8M | 97% |
| Financial Services | $28.1M | 3% |
| Management Fees | $7.1M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
